Alexis Jaramillo Cartagena, PhD, D(ABMM)

Alexis Jaramillo Cartagena, PhD, D(ABMM)

@alexclinmicro.bsky.social

🔬 Assistant Prof, Pathology ‪@Duke | Director, Clin Micro Lab 🧫 Former Clin Micro Fellow ‪@Memorial Sloan Kettering 👩🏻‍🔬 Former Postdoc @broadinstitute.org 🎓 PhD @The Rockefeller University Focus: Diagnostics, AMR, Structural Biology

3,062 Followers 2,526 Following 32 Posts Joined May 2025
2 months ago

So well deserved! 🎉 Huge congratulations to Leslie—what an amazing accomplishment. It’s awesome to see your hard work recognized at ABRCMS 2025!

2 0 0 0
4 months ago
Preview
Madonna opens up about surviving sepsis: 'It can kill you' Madonna is opening up about her bout with sepsis in a new episode of the "On Purpose" podcast with Jay Shetty.

#Madonna opens up about surviving #Sepsis: 'It can kill you'

#sepsiskills #sepsisdoesnotdiscriminate #SepticShock @sepsiscanada.bsky.social @patientled.bsky.social @sepsisalliance.bsky.social @sepsisresearch.bsky.social #medsky @endsepsis.bsky.social
abcnews.go.com/GMA/Wellness...

5 3 0 0
5 months ago
Post image

Preparing for the ABMM was humbling—I left the exam feeling defeated 😔. Today, seeing the certificate with my name reminds me it’s real 🤏🙌. Grateful, humbled, and excited to keep learning and serving in this field 💡🧫✨.

36 2 2 0
5 months ago

Congrats, Laura!!!

1 0 0 0
5 months ago

Wow!

2 0 0 0
5 months ago

On #WorldSepsisDay, huge thanks to all the clinicians, nurses, lab professionals & researchers working to detect, treat & prevent #Sepsis. Your advances in diagnostics & therapies save lives every day. 💙 #PatientSafety #GlobalHealth #Infection #CriticalCare #MedTwitter

22 8 0 0
6 months ago

Truly a rewarding journey — honored to be part of it! Huge thanks to @roby-b.bsky.social for your dedication and invaluable mentorship throughout. Your guidance made all the difference for everyone involved. Learned so much through this process 🙏

17 0 0 0
6 months ago

Thank you!!!

1 0 0 0
6 months ago
Preview
Dr. Beth Shaz’s Study Aims to Streamline Production of Promising Cancer Therapy Professor Beth Shaz, MD, MBA, helped lead a study to advance efforts to make tumor-infiltrating lymphocyte (TIL) therapy more accessible to cancer patients. TIL therapy, which uses a patient’s own imm...

Game-changing #TIL therapy advance! 🚀 Dr. Beth Shaz’s new protocol cuts production to 4 wks using T-cell media + AB serum + α-CD3/CD28 nanobeads (no feeder cells). Faster, efficient, scalable—opening doors for more patients. #CancerImmunotherapy

8 1 0 0
6 months ago

Thank you, Roby!!!

0 0 0 0
6 months ago

Muchas gracias, Leonor!!!

1 0 1 0
6 months ago

Congrats Jaye!!!

1 0 1 0
6 months ago

Thank you, Victor!!!

1 0 0 0
6 months ago

Thank you!!!

0 0 0 0
6 months ago
Preview
Jonathan Chen Named to ASCP 40 Under Forty List On August 29, 2025, the American Society for Clinical Pathology (ASCP) named Duke Pathologists’ Assistant Jonathan Chen, MHS, PA(ASCP) to its prestigious

Jonathan Chen Named to ASCP 40 Under Forty List pathology.duke.edu/news/jonatha...

5 0 0 0
6 months ago

I loved the ~10ish years I lived in the UES, but this is out of control 😱😱😱

9 1 0 0
6 months ago

Thank you Sarah! I hope you're having at MGB and in Boston! I'm so glad to see some of your great efforts like the VRE molecular epidemiology study!

0 0 0 0
6 months ago
A diagram showing screening and randomization.

In a randomized, controlled trial, persons with early syphilis received a single treatment or three treatments with benzathine penicillin G at a dose of 2.4 million units. No benefit was seen with the additional doses. Full trial results: nej.md/3UVCKVZ

#MedSky #IDSky

24 9 1 5
6 months ago

✨ Excited to dive into tomorrow’s seminar on molecular epidemiology by Robert Potter @plasmidsaurus.bsky.social @childrensphila.bsky.social 🔬🧬
Looking forward to learning a ton from this terrific session! 🚀📚 #ClinicalMicrobiology www.chop.edu/doctors/pott...

5 0 0 0
6 months ago
Preview
Annual Book Development Prize Competition Rules and Entry Form The Society for the Social History of Medicine (SSHM) invites submissions to its Annual Book Development Award Competition. The Award Two awards of £2000.00 each will be given …

📣Annual Book Development Prize Competition 📣
Submissions are now invited for the 2026 Award, which funds authors to turn a proposal into a book in the Social Histories of Medicine series, published by @manchesterup.bsky.social Applications are accepted on a rolling basis until 16 Jan 2026.
#histmed

35 25 0 2
6 months ago

This is amazing Sarah @microbecharmer.bsky.social !! I love how each cell in the fusarium macroconidia has its own personality!!!

4 0 2 0
1 year ago
A pink flyer with a darker outline of a uterus and fallopian tubes that says "We need your help investigating menstrual product use and the vaginal microbiome."
Why: Researchers from Duke University are conducting a study investigating if menstrual products advertised as scented or for odor control affect the vaginal microbiome compared to unscented menstrual products.
How: If you agree to participate you will be asked to: (each of the bullet points is shaped like a tampon)
Self-collect vaginal swabs during 4 menstrual cycles for microbiome assessment.
Complete a short questionnaire each cycle.
Complete a demographic and short health history questionnaire.
Use study-provided menstrual products during 2 menstrual cycles
(one cycle you will use scented/odor control products and one cycle you will use unscented products).
Who: Up to 50 of individuals aged 18-40 years who have regular menstrual cycles (approximately every 4 weeks) that last at least 3 days, can safely use tampons, do not have allergies/hypersensitivity to fragrances, are not or do not plan to become pregnant over the study period will take part in this study, and have not given birth in the past 12 months.
Compensation for your time will be provided.

There's a drop of blood with a QR code on it where you can learn more - I'll post that separately!

Do you have a period?
Do you live in the continental US?
Then do I have a study for you - please join VAMPP and help expand our understanding of the vaginal microbiome!
Scan the QR code on the bottom left to see if you're eligible and learn more

6 3 1 1
6 months ago

Thank you, Kasia!!!

2 0 0 0
6 months ago
Post image

Probably the prettiest bird species iv ever seen. The Lilac Breasted Roller! 😍 #bird #birdphotography #birdlovers #nature #naturephotography #tranquillity #lovelife #mindfulness #nikon #nikonbirds #nikonwildlife #nikonwildlifephotography #bbcerth #discover

58 10 3 0
6 months ago
Pasteur-Paris University International Doctoral Programme, The call for enrollment of students in October 2026 will be open from September 1st to October 20th, 2025

🎓 Applications for Institut Pasteur's PhD programs open Sept 1-Oct 20, 2025 for October 2026 entry.

Apply to up to 4 projects across 6 programs: PPU, PPU-IMAGINE @institutimagine.bsky.social, PPU-@ox.ac.uk, PPU-EID @upcite.bsky.social & more 🧬

Register now ✍️ www.pasteur.fr/en/education...

33 34 0 6
6 months ago
various views of microbial cells

New #ISEPpapers! Regulated development of cannibalistic supergiant cells www.biorxiv.org/content/10.1...

"we describe a ciliate undergoing drastic morphological transformations... supergiants increase in size, change shape, and modify behaviour to cannibalize clonal relatives"

#protists #microbes

21 2 1 0
6 months ago

We are hiring! Please circulate in your networks. Join us in beautiful warm and wonderful KZN to answer some important questions about asymptomatic / subclinical TB.

#TBsky #IDsky 🧪

4 6 1 0
6 months ago

The 2024 rankings of bacterial threats

66 36 4 4
6 months ago

Thank you, Valerie!!!

0 0 0 0
6 months ago
Preview
Dr. Beth Shaz’s Study Aims to Streamline Production of Promising Cancer Therapy Professor Beth Shaz, MD, MBA, helped lead a study to advance efforts to make tumor-infiltrating lymphocyte (TIL) therapy more accessible to cancer patients. TIL therapy, which uses a patient’s own imm...

Dr. Beth Shaz’s Study Aims to Streamline Production of Promising Cancer Therapy pathology.duke.edu/news/dr-beth...

1 0 0 0